The Board of Directors of the Cyprus Association of Research & Development Pharmaceutical Companies (KEFEA) held a meeting on 31 January 2024 and decided as follows: With regard to section 19.9 of its Code of Conduct, KEFEA has made the decision to renew its white...
December 15, 2022 With regard to section 19.9 of its Code of Conduct, KEFEA has made the decision to establish a white list of 5* hotels in Cyprus, in which KEFEA members may hold and sponsor events, should they wish to do so. The white list was considered necessary...
With regard to section 19.9 of its Code of Conduct, KEFEA has made the decision to establish a white list of 5* hotels in Cyprus, in which KEFEA members may hold and sponsor events, should they wish to do so. The white list was considered necessary due to the paucity...
The basic criteria for the system’s success *By Kyriakos Mikellis The provision of healthcare services to Cypriot citizens through the implementation of a functional, efficient and sustainable health system is something that should have happened many years ago. The...
Paves the way to improve patients’ access to innovative medicines The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the vote on the NHS bill by the House of Representatives Plenum. This is an important moment for the Republic...
